Rejuve.AI 的長壽生態系統透過加密貨幣的採用而增強

長壽研究平台 Rejuve.AI 宣布與 GlycanAge、Vita Authentica 和 Peptide Bioregulator 建立合作夥伴關係，使消費者能夠使用 RJV 加密代幣購買他們的產品。這些合作夥伴關係允許個人透過 Rejuve.AI 的長壽應用程式將其健康數據貨幣化，同時透過為新療法和療法的開發提供有價值的數據來為長壽研究做出貢獻。

Rejuve.AI's Longevity Ecosystem Expands with Crypto Payment Adoption

Rejuve.AI 的長壽生態系統隨著加密支付的採用而擴展

SINGULARITYNET'S HEALTHCARE FORAY GAINS MOMENTUM

SINGULARITYNET 的醫療保健進軍勢頭強勁

San Francisco, California - Rejuve.AI, a pioneering longevity AI company operating within the SingularityNET ecosystem, has announced a groundbreaking partnership with three prominent consumer health brands: GlycanAge, Vita Authentica, and Peptide Bioregulator. This collaboration marks a transformative step towards democratizing longevity research and healthy aging through the integration of blockchain and AI.

加州舊金山 - Rejuve.AI 是一家在 SingularityNET 生態系統中運營的領先長壽人工智慧公司，宣布與三個著名的消費者健康品牌建立突破性的合作夥伴關係：GlycanAge、Vita Authentica 和 Peptide Bioregulator。此次合作標誌著透過區塊鏈和人工智慧的整合，朝著民主化長壽研究和健康老化邁出了變革性的一步。

The three partner brands will now accept Rejuve.AI's native cryptocurrency, RJV, as payment for their products and services. This move not only enhances the accessibility of personalized longevity solutions but also contributes significantly to the burgeoning longevity sector.

這三個合作品牌現在將接受 Rejuve.AI 的原生加密貨幣 RJV 作為其產品和服務的付款方式。此舉不僅提高了個人化長壽解決方案的可及性，而且為蓬勃發展的長壽產業做出了重大貢獻。

REJUVENATING LONGEVITY RESEARCH THROUGH DECENTRALIZATION

通過去中心化振興長壽研究

Rejuve.AI's decentralized longevity research platform empowers individuals to share their medical, lifestyle, and biological data. Leveraging AI's transformative capabilities, the platform translates this vast data into actionable insights that guide personalized longevity strategies.

Rejuve.AI 的去中心化長壽研究平台使個人能夠分享他們的醫療、生活方式和生物數據。該平台利用人工智慧的變革能力，將大量數據轉化為可操作的見解，指導個人化的長壽策略。

The Longevity App, developed by Rejuve.AI, provides a comprehensive platform for users to submit their health data from various sources, including surveys, lab results, and wearable devices. In return for sharing their valuable health information, users receive RJV tokens redeemable for products and services offered by Rejuve.AI's partner brands.

Longevity App 由 Rejuve.AI 開發，為使用者提供了一個綜合平台，可以從各種來源提交健康數據，包括調查、實驗室結果和穿戴式裝置。作為分享寶貴健康資訊的回報，用戶將獲得 RJV 代幣，可兌換 Rejuve.AI 合作夥伴品牌提供的產品和服務。

This data-sharing mechanism not only monetizes users' health data but also fuels the advancement of longevity research. The data collected through the Longevity App contributes to the development of new drugs, therapies, and treatments, ultimately benefiting humanity's pursuit of healthier and longer lives.

這種數據共享機制不僅可以將用戶的健康數據貨幣化，還可以推動長壽研究的進步。透過長壽應用程式收集的數據有助於新藥、療法和療法的開發，最終有利於人類追求更健康、更長壽的生活。

REJUVENATING TREATMENT DEVELOPMENT THROUGH BIOLOGICAL INSIGHTS

透過生物學見解進行復興療法的開發

Rejuve.Bio, a fellow SingularityNET company, capitalizes on the insights generated by Rejuve.AI to develop and commercialize innovative experimental therapies. The partnership with consumer health brands like GlycanAge, Vita Authentica, and Peptide Bioregulator further strengthens Rejuve.Bio's efforts to bring transformative longevity solutions to market.

Rejuve.Bio 是 SingularityNET 旗下的公司，它利用 Rejuve.AI 產生的見解來開發創新的實驗療法並將其商業化。與 GlycanAge、Vita Authentica 和 Peptide Bioregulator 等消費者健康品牌的合作進一步加強了 Rejuve.Bio 將變革性長壽解決方案推向市場的努力。

EMBRACING THE VALUE OF LONGEVITY RESEARCH

擁抱長壽研究的價值

The decision by GlycanAge, Vita Authentica, and Peptide Bioregulator to accept RJV tokens reflects their unwavering belief in the transformative power of longevity research.

GlycanAge、Vita Authentica 和 Peptide Bioregulator 接受 RJV 代幣的決定反映了他們對長壽研究的變革力量的堅定信念。

"We are thrilled to see the industry recognizing the crucial role that crypto plays in healthcare and longevity research," said Jasmine Smith, CEO of Rejuve.AI. "Our partnership with these leading brands demonstrates our commitment to realizing our mission of pioneering groundbreaking longevity research and innovation."

Rejuve.AI 執行長 Jasmine Smith 表示：“我們很高興看到業界認識到加密貨幣在醫療保健和長壽研究中發揮的關鍵作用。” “我們與這些領先品牌的合作表明我們致力於實現開創性的長壽研究和創新的使命。”

CONCLUSION

結論

The integration of RJV crypto tokens into the offerings of GlycanAge, Vita Authentica, and Peptide Bioregulator marks a significant milestone in the advancement of longevity research. This collaboration opens new avenues for funding, incentivizing data sharing, and fostering innovation within the longevity sector. As the adoption of RJV tokens expands, Rejuve.AI and its partners continue to reshape the future of healthy aging, empowering individuals and researchers alike to unlock the potential of a longer, healthier life.

將 RJV 加密代幣整合到 GlycanAge、Vita Authentica 和 Peptide Bioregulator 的產品中，標誌著長壽研究進展的一個重要里程碑。此次合作開闢了新的融資途徑，激勵數據共享，並促進長壽領域的創新。隨著 RJV 代幣的採用範圍擴大，Rejuve.AI 及其合作夥伴繼續重塑健康老化的未來，使個人和研究人員能夠釋放更長壽、更健康生活的潛力。